Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chew

Showing results (361-370 of 487) with videos related to

Pageof 49
Sort By:
Heart, Lung & Circulation|September 5, 2017
Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952Derek P Chew, Ian A Scott, Louise Cullen, et al.
Heart, Lung & Circulation|August 2, 2016
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016Derek P Chew, Ian A Scott, Louise Cullen, et al.
Heart, Lung & Circulation|May 21, 2013
Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency departmentLouise Cullen, Jaimi Greenslade, Christopher J Hammett, et al.
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosisStephen G Worthley, Gérard Helft, Roberto Corti, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
Nature Reviews. Cardiology|February 11, 2026
Inherited risk of coronary artery disease: redefining care with imaging and geneticsNick S R Lan, Girish Dwivedi, Graham S Hillis, et al.
Internal Medicine Journal|September 22, 2015
Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?B Pathik, C G De Pasquale, A D McGavigan, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Heart, Lung & Circulation|November 22, 2023
Variability in Contemporary Heparin Prescription and Activated Clotting Time Monitoring During Percutaneous Coronary Intervention: Call for Up-To-Date Evidence-Based GuidelinesOmar Al-Mukhtar, Dion Stub, Christopher M Reid, et al.
International Journal of Cardiology|January 31, 2016
Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010Tom Briffa, Joseph Hung, Matthew Knuiman, et al.
Pageof 49

Showing results (361-370 of 487) with videos related to

Sort By:
Pageof 49
Heart, Lung & Circulation|September 5, 2017
Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952Derek P Chew, Ian A Scott, Louise Cullen, et al.
Heart, Lung & Circulation|August 2, 2016
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016Derek P Chew, Ian A Scott, Louise Cullen, et al.
Heart, Lung & Circulation|May 21, 2013
Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency departmentLouise Cullen, Jaimi Greenslade, Christopher J Hammett, et al.
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosisStephen G Worthley, Gérard Helft, Roberto Corti, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
Nature Reviews. Cardiology|February 11, 2026
Inherited risk of coronary artery disease: redefining care with imaging and geneticsNick S R Lan, Girish Dwivedi, Graham S Hillis, et al.
Internal Medicine Journal|September 22, 2015
Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?B Pathik, C G De Pasquale, A D McGavigan, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Heart, Lung & Circulation|November 22, 2023
Variability in Contemporary Heparin Prescription and Activated Clotting Time Monitoring During Percutaneous Coronary Intervention: Call for Up-To-Date Evidence-Based GuidelinesOmar Al-Mukhtar, Dion Stub, Christopher M Reid, et al.
International Journal of Cardiology|January 31, 2016
Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010Tom Briffa, Joseph Hung, Matthew Knuiman, et al.
Pageof 49